Geron's Stem Cell Bust Leaves Investors Holding the Bag

Wall Street not likely to fund new stem cell ventures in the wake of Geron's failure.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!